Suppr超能文献

肝细胞癌调强放疗后非典型放射性肝病(ncRILD)的危险因素

Risk Factors of Non-Classic Radiation-Induced Liver Disease (ncRILD) After Intensity-Modulated Radiotherapy in Hepatocellular Carcinoma.

作者信息

Du You-Qin, Tao Su-Ping, Li Jian-Xu, Zhao Yin-Nong

机构信息

Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China.

Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China.

出版信息

Cancer Manag Res. 2025 Jun 18;17:1169-1183. doi: 10.2147/CMAR.S539527. eCollection 2025.

Abstract

PURPOSE

This study aimed to identify independent risk factors for non-classic radiation-induced liver disease (ncRILD) in hepatocellular carcinoma (HCC) patients treated with intensity-modulated radiation therapy (IMRT) and to construct a predictive nomogram.

PATIENTS AND METHODS

We retrospectively analyzed 177 primary HCC patients treated with IMRT between 2013 and 2021. Univariate and multivariate analyses were conducted to identify risk factors for ncRILD. A nomogram was developed based on significant variables. Dosimetric parameters were also assessed across different fractionation doses.

RESULTS

Multivariate analysis identified tumor number ≥ 2, mean liver dose ≥ 1371.4 cGy, and normal liver volume < 700 mL as independent risk factors for ncRILD. A nomogram was established using logistic regression. In patients receiving ≥ 4 Gy per fraction, ncRILD was significantly associated with Vs5-Vs40 (p < 0.05), but not with V5-V40. No such associations were found for 2 Gy and 3 Gy groups.

CONCLUSION

Patients with multifocal tumor, lower normal liver volume and higher mean liver dose are at increased risk of developing radiation-induced liver injury. These findings suggest that dosimetric parameters, especially at higher fraction doses, may play a critical role in the occurrence of ncRILD.

摘要

目的

本研究旨在确定接受调强放射治疗(IMRT)的肝细胞癌(HCC)患者发生非典型放射性肝病(ncRILD)的独立危险因素,并构建预测列线图。

患者与方法

我们回顾性分析了2013年至2021年间接受IMRT治疗的177例原发性HCC患者。进行单因素和多因素分析以确定ncRILD的危险因素。基于显著变量开发了列线图。还评估了不同分割剂量下的剂量学参数。

结果

多因素分析确定肿瘤数量≥2、平均肝脏剂量≥1371.4 cGy和正常肝脏体积<700 mL为ncRILD的独立危险因素。使用逻辑回归建立了列线图。在每次分割剂量≥4 Gy的患者中,ncRILD与Vs5-Vs40显著相关(p<0.05),但与V5-V40无关。在2 Gy和3 Gy组中未发现此类关联。

结论

多灶性肿瘤、正常肝脏体积较小和平均肝脏剂量较高的患者发生放射性肝损伤的风险增加。这些发现表明剂量学参数,尤其是在较高分割剂量下,可能在ncRILD的发生中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c3/12182741/7a04671c55da/CMAR-17-1169-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验